SCHEMBL4281377

SCHEMBL4281377

CCN1C[CH]CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17294453 0.77 — —
SCHEMBL25397254 0.71 L3MBTL1 (0.56) —
SCHEMBL1826694 0.70 — —
SCHEMBL1894549 0.69 — —
SCHEMBL16327594 0.67 — —
SCHEMBL18635 0.65 — —
SCHEMBL14423078 0.65 — —
SCHEMBL179071 0.64 — —
Water SCHEMBL6122968 0.64 PIK3CD (0.57) —
Hydrochloric Acid SCHEMBL23248746 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116507608-A Compounds, compositions, and methods 戴纳立制药公司 2023-07-28 — — CN claimed
CN-116507608-A Compounds, compositions, and methods 戴纳立制药公司 2023-07-28 — — CN disclosed
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 — — EP disclosed
US-20090176307-A1 Compounds, Compositions and Methods CYTOKINETICS, INC. 2009-07-09 — — US disclosed
US-7491826-B2 Compounds, compositions and methods CYTOKINETICS, INC. (US) 2009-02-17 — — US disclosed
US-7399866-B2 Compounds, compositions, and methods CYTOKINETICS, INC. (US) 2008-07-15 — — US disclosed
US-20060241110-A1 Compounds, compositions, and methods CYTOKINETICS, INCORPORATED 2006-10-26 — — US disclosed
US-20050159416-A1 Compounds, compositions and methods CYTOKINETICS, INCORPORATED 2005-07-21 — — US disclosed
Send feedback